| academic journal | Q737498 |
| open-access journal | Q773668 |
| scientific journal | Q5633421 |
| P8375 | Crossref journal ID | 198985 |
| P5115 | Directory of Open Access Journals ID | 2050-7771 |
| P8903 | HAL journal ID | 107618 |
| P236 | ISSN | 2050-7771 |
| P7363 | ISSN-L | 2050-7771 |
| P4730 | Mir@bel journal ID | 9606 |
| P1055 | NLM Unique ID | 101607860 |
| P856 | official website | http://biomarkerres.biomedcentral.com/ |
| http://www.biomarkerres.org/ | ||
| P10283 | OpenAlex ID | S2764853569 |
| P3181 | OpenCitations bibliographic resource ID | 13092 |
| P12834 | PMC journal ID | 2201 |
| P7662 | Scilit journal ID | 1463131 |
| P1156 | Scopus source ID | 21100853949 |
| P5983 | Springer journal ID | 40364 |
| P4616 | UniProt journal ID | 4514 |
| P166 | award received | DOAJ seal | Q73548471 |
| P972 | catalog | Directory of Open Access Journals | Q1227538 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P17 | country | United Kingdom | Q145 |
| P495 | country of origin | United Kingdom | Q145 |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| Science Citation Index Expanded | Q104047209 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P123 | publisher | Springer Science+Business Media | Q176916 |
| BioMed Central | Q463494 | ||
| P1476 | title | Biomarker research |
| Q38621233 | "UPRegulation" of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses |
| Q35132001 | A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature |
| Q104133344 | A DNA methylation-based test for esophageal cancer detection |
| Q42367256 | A case of B-cell acute lymphoblastic leukemia in a child with Down syndrome bearing a t(2;12)(p12;p13) involving ETV6 and biallelic IGH@ rearrangements |
| Q34256192 | A case of pediatric B-Lymphoblastic leukemia presenting with a t(9;12)(p24;q11.2) involving JAK2 and concomitant MLL rearrangement with apparent insertion at 6q27 |
| Q37633632 | A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition |
| Q99630567 | A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression |
| Q35368806 | A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes |
| Q36409921 | A meta-analysis of hypoxia inducible factor 1-alpha (HIF1A) gene polymorphisms: association with cancers |
| Q98907307 | A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19) |
| Q37522576 | A new method for maturity-dependent fractionation of neutrophil progenitors applicable for the study of myelodysplastic syndromes |
| Q34538733 | A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature |
| Q43083508 | A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients |
| Q36513623 | A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia |
| Q128466916 | A patient with multiple primary malignant neoplasms with high variant allele frequencies of RB1, TP53, and TERT |
| Q92188218 | A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab |
| Q99609266 | A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data |
| Q38637619 | A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia. |
| Q36599994 | A robust prognostic gene expression signature for early stage lung adenocarcinoma |
| Q40920244 | A striking response of plasmablastic lymphoma of the oral cavity to bortezomib: a case report |
| Q98576962 | AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report |
| Q55161237 | Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2+/− mice and mouse mesothelioma cell lines from various mouse strains. |
| Q49873907 | Acute myeloid leukemia in a father and son with a germline mutation of ASXL1. |
| Q28079105 | Advance in microRNA as a potential biomarker for early detection of pancreatic cancer |
| Q99565746 | Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer |
| Q96024451 | Advances in targeted therapy for acute myeloid leukemia |
| Q104133232 | Alternative Polyadenylation: a new frontier in post transcriptional regulation |
| Q112701712 | Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer |
| Q28077952 | Application of multi-target phytotherapeutic concept in malaria drug discovery: a systems biology approach in biomarker identification |
| Q30252953 | Application of penalized linear regression methods to the selection of environmental enteropathy biomarkers |
| Q98613207 | Application of pharmacogenetics in oncology |
| Q57193553 | Aptamer-based search for correlates of plasma and serum water T: implications for early metabolic dysregulation and metabolic syndrome |
| Q42682509 | Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer |
| Q104133286 | Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study |
| Q128491998 | Association between circulating ECM-associated molecules and cardiovascular outcomes in hemodialysis patients: a multicenter prospective cohort study |
| Q55264458 | Associations of single nucleotide polymorphisms with mucinous colorectal cancer: genome-wide common variant and gene-based rare variant analyses. |
| Q33440971 | Autoimmune hemolytic anemia associated with babesiosis |
| Q28397624 | BAP1 hereditary cancer predisposition syndrome: a case report and review of literature |
| Q34255880 | Beyond malignancy: the role of carbohydrate antigen 125 in heart failure |
| Q98576968 | Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions |
| Q104133781 | Biomarkers for cancer-associated fibroblasts |
| Q34256150 | Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy |
| Q33424563 | Biomarkers for immune thrombocytopenia |
| Q95274320 | Biomarkers in individualized management of chimeric antigen receptor T cell therapy |
| Q43165722 | Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. |
| Q49878390 | Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy |
| Q33702810 | Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives |
| Q30234676 | Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review |
| Q101039830 | CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia |
| Q38186870 | CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies |
| Q28072550 | CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia |
| Q42717244 | CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function |
| Q34256170 | CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers |
| Q91740150 | Cancer biomarkers for targeted therapy |
| Q125908719 | Cancer metabolites: promising biomarkers for cancer liquid biopsy |
| Q104794051 | Cancer-associated adipocytes as immunomodulators in cancer |
| Q125703297 | Cervical cancer heterogeneity: a constant battle against viruses and drugs |
| Q35710253 | Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup |
| Q95265960 | Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma |
| Q55297751 | Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes. |
| Q96231530 | Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth |
| Q42148263 | Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis |
| Q95265963 | Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies |
| Q36671801 | Circulating micrornas associated with glycemic impairment and progression in Asian Indians |
| Q33668173 | Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer. |
| Q33964995 | Circumventing qPCR inhibition to amplify miRNAs in plasma |
| Q96822676 | Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients |
| Q34255861 | Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma |
| Q33660469 | Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing |
| Q91897487 | Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma |
| Q58793391 | Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia |
| Q47827523 | Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort. |
| Q42155445 | Comparative study of two protocols for quantitative image-analysis of serotonin transporter clustering in lymphocytes, a putative biomarker of therapeutic efficacy in major depression |
| Q92557340 | Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer |
| Q104133805 | Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why? |
| Q54940876 | Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer. |
| Q90862327 | Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia |
| Q104801918 | Correction to: Length of hospitalization is associated with selected biomarkers (albumin and lymphocytes) and with co-morbidities: study on 4000 patients |
| Q47120654 | Critical appraisal of the role of serum albumin in cardiovascular disease |
| Q92573581 | Cyclin D1 + large B-cell lymphoma with altered CCND1 and BCL-6 rearrangements: a diagnostic challenge |
| Q92005886 | DLGAP1 directs megakaryocytic growth and differentiation in an MPL dependent manner in hematopoietic cells |
| Q33617129 | DNA methylation: potential biomarker in Hepatocellular Carcinoma. |
| Q37597292 | DNA methyltransferases and their roles in tumorigenesis |
| Q28072119 | Dental implant bioactive surface modifications and their effects on osseointegration: a review |
| Q41449039 | Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH |
| Q35025061 | Detection of Epstein-Barr virus (EBV) in human lymphoma tissue by a novel microbial detection array |
| Q37504925 | Development and validation of a novel bioassay to determine glucocorticoid sensitivity. |
| Q35185468 | Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface |
| Q42377458 | Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer |
| Q98576965 | Development of a highly sensitive method for detection of FLT3D835Y |
| Q47653029 | Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study |
| Q39132786 | Diagnosis and treatment of CD20 negative B cell lymphomas |
| Q52723665 | Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development. |
| Q35789307 | Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. |
| Q61445635 | Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma |
| Q104133824 | Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function |
| Q56518873 | Dysregulated transcriptional networks in and -rearranged T-ALL |
| Q38164139 | Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application |
| Q37180302 | EGFR inhibition in non-small cell lung cancer: current evidence and future directions |
| Q59790124 | EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies |
| Q41790787 | Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells |
| Q64112796 | Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma |
| Q33893145 | Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke |
| Q39399864 | Engineering CAR-T cells |
| Q104133745 | Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing |
| Q34255973 | Enhanced expression of a 35 kDa fragment of inter-alpha-trypsin inhibitor H4 in sera of healthy pregnant women and patients with hydatidiform mole |
| Q112293386 | Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study |
| Q99711836 | Epigenetic based synthetic lethal strategies in human cancers |
| Q91155589 | Epigenetic heterogeneity in cancer |
| Q52349529 | Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. |
| Q43191152 | Erratum to: A case of B-cell acute lymphoblastic leukemia in a child with Down syndrome bearing a t(2;12)(p12;p13) involving ETV6 and biallelic IGH@ rearrangements |
| Q55317458 | Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status: a case control study. |
| Q36871720 | Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia. |
| Q90137009 | Evaluation of breast stiffness measured by ultrasound and breast density measured by MRI using a prone-supine deformation model |
| Q47139923 | Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients |
| Q64075034 | Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm |
| Q36903912 | Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma |
| Q34256185 | Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women |
| Q99711837 | Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis |
| Q112698544 | Extracellular miR-6723-5p could serve as a biomarker of limbal epithelial stem/progenitor cell population |
| Q37228642 | Extramedullary hematopoiesis presented as cytopenia and massive paraspinal masses leading to cord compression in a patient with hereditary persistence of fetal hemoglobin |
| Q100416716 | FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients |
| Q56526565 | Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour |
| Q37567005 | Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine |
| Q26741090 | Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management |
| Q91155595 | Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia |
| Q33913937 | Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy |
| Q90137004 | Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia |
| Q35748107 | Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets. |
| Q59132371 | Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts |
| Q35519456 | High adiponectin levels in lean Arab women compared to Asian women |
| Q33794854 | High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death |
| Q114749756 | High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma |
| Q41127165 | Higher plasma prorenin concentration plays a role in the development of coronary artery disease |
| Q33785036 | Higher serum concentrations of vimentin and DAKP1 are associated with aggressive breast tumour phenotypes in Ghanaian women |
| Q38960418 | Hypercalcemia associated with isolated bone marrow sarcoidosis in a patient with underlying monoclonal gammopathy of undetermined significance: case report and review of literature |
| Q40161325 | IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt's lymphoma |
| Q64975487 | Identification of TCR Vβ11-2-Dβ1-Jβ1-1 T cell clone specific for WT1 peptides using high-throughput TCRβ gene sequencing. |
| Q41968203 | Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology |
| Q89639028 | Identification of pAKT as a pharmacodynamic marker for MER kinase in human melanoma G361 cells |
| Q37697844 | Identification of potential serum biomarkers for breast cancer using a functional proteomics technology |
| Q39005998 | Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients |
| Q37180312 | Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model |
| Q91897494 | Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1 |
| Q112722132 | Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia |
| Q91937343 | Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer |
| Q97645206 | Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcome |
| Q42322772 | Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma |
| Q89821722 | Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML |
| Q99565747 | Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL |
| Q64053139 | Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma |
| Q42219681 | Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker. |
| Q42121983 | Integrin α1 subunit is up-regulated in colorectal cancer |
| Q47151593 | Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso |
| Q114871386 | Intratumor microbiome in cancer progression: current developments, challenges and future trends |
| Q90676502 | Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma |
| Q90979806 | Isocitrate dehydrogenase inhibitors in acute myeloid leukemia |
| Q41499758 | JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association? |
| Q55324328 | Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose. |
| Q128659945 | LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin |
| Q92540390 | LOX family and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma |
| Q37713538 | Length of hospitalization is associated with selected biomarkers (albumin and lymphocytes) and with co-morbidities: study on 4000 patients. |
| Q104133489 | Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML |
| Q99565744 | LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers |
| Q90015173 | LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer |
| Q101039827 | Long interspersed nuclear element 1 hypomethylation has novel prognostic value and potential utility in liquid biopsy for oral cavity cancer |
| Q64288374 | Longitudinal study of leukocyte DNA methylation and biomarkers for cancer risk in older adults |
| Q112611449 | Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome |
| Q36126155 | Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysis |
| Q37180308 | Lung cancer screening: from imaging to biomarker |
| Q100519058 | Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer |
| Q96345885 | Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia |
| Q128964240 | MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma |
| Q31157242 | Machine learning and systems genomics approaches for multi-omics data |
| Q64239878 | Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy |
| Q28071848 | Mechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends |
| Q100727677 | Mechanisms of tRNA-derived fragments and tRNA halves in cancer treatment resistance |
| Q96231527 | Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies |
| Q92968069 | Mesothelin as a biomarker for targeted therapy |
| Q34256164 | Metabolomic analyses for atherosclerosis, diabetes, and obesity |
| Q37630943 | Metastatic biomarkers in synovial sarcoma |
| Q26823660 | Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment |
| Q34417467 | MicroRNAs as promising biomarkers in cancer diagnostics |
| Q113241592 | MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer |
| Q104133608 | Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma |
| Q59130314 | Molecular landscape and targeted therapy of acute myeloid leukemia |
| Q38164164 | Molecular signatures of chronic myeloid leukemia stem cells |
| Q38176479 | Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases |
| Q37714981 | Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib |
| Q34347935 | Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia |
| Q104133761 | N6-methyladenine modification in noncoding RNAs and its function in cancer |
| Q55313423 | NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors. |
| Q38996298 | NOS1-, NOS3-, PIK3CA-, and MAPK-pathways in skin following radiation therapy |
| Q35186744 | Nephrin - a biomarker of early glomerular injury |
| Q125601497 | Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target |
| Q42918999 | New urinary biomarkers for diabetic kidney disease |
| Q34256132 | Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. |
| Q28680693 | Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials |
| Q92647353 | Novel immunomodulatory drugs and neo-substrates |
| Q64078436 | Novel insights into MSC-EVs therapy for immune diseases |
| Q100466436 | Novel insights on targeting ferroptosis in cancer therapy |
| Q33112692 | Nuclear protein IK undergoes dynamic subcellular translocation and forms unique nuclear bodies during the cell cycle |
| Q114925676 | Nucleases as molecular targets for cancer diagnosis |
| Q59790121 | OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus |
| Q94527064 | Overexpressed immunoglobulin-like transcript (ILT) 4 in lung adenocarcinoma is correlated with immunosuppressive T cell subset infiltration and poor patient outcomes |
| Q59137546 | Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers |
| Q104133808 | PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo |
| Q52590724 | PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge. |
| Q89496404 | PSCA is a target of chimeric antigen receptor T cells in gastric cancer |
| Q26775693 | Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects |
| Q41064551 | Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs |
| Q43224150 | Pattern and prevelence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria |
| Q41870083 | Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report |
| Q59336102 | Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis |
| Q56526175 | Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma |
| Q34256144 | Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms |
| Q97645211 | Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma |
| Q37494206 | Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis. |
| Q48222655 | Platelet protein biomarker panel for ovarian cancer diagnosis |
| Q61448590 | Pluripotency markers are differentially induced by IGF1 and bFGF in cells from patients' lesions of large/giant congenital melanocytic nevi |
| Q37697790 | Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study |
| Q34256178 | Polymorphisms of Toll-like receptor-4 and CD14 in systemic lupus erythematosus and rheumatoid arthritis |
| Q120160629 | Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction |
| Q99630568 | Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors |
| Q34256198 | Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM) |
| Q55059516 | Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutation. |
| Q38552579 | Prognostic models for alcoholic hepatitis |
| Q37169644 | Prognostic significance of miR-194 in endometrial cancer. |
| Q42918890 | Prognostic value and functional consequences of cell cycle inhibitor p27Kip1 loss in medulloblastoma |
| Q34256139 | Proprotein convertases in high-density lipoprotein metabolism |
| Q49634633 | Protein kinase inhibitors for acute leukemia |
| Q129309745 | Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation |
| Q36577713 | RECQ helicases are deregulated in hematological malignancies in association with a prognostic value |
| Q42118491 | Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders |
| Q99557890 | Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia |
| Q104133030 | Recent updates on Sintilimab in solid tumor immunotherapy |
| Q104133978 | Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia |
| Q99565745 | Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy |
| Q60925433 | Reduced nuclear DNA methylation and mitochondrial transcript changes in adenomas do not associate with mtDNA methylation |
| Q104133651 | Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells |
| Q99630570 | Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives |
| Q40156397 | Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma |
| Q35033342 | RiGoR: reporting guidelines to address common sources of bias in risk model development |
| Q96954202 | Role of DNA repair defects in predicting immunotherapy response |
| Q128626515 | Role of HOXA1-4 in the development of genetic and malignant diseases |
| Q98290004 | Role of platelet biomarkers in inflammatory response |
| Q96579001 | Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment |
| Q100416717 | Roles of IFN-γ in tumor progression and regression: a review |
| Q38267622 | Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis |
| Q47747424 | SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis |
| Q47140333 | SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome |
| Q26767439 | SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma |
| Q57069030 | SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms |
| Q112701623 | SRTdb: an omnibus for human tissue and cancer-specific RNA transcripts |
| Q98893956 | Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report |
| Q92580247 | Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading? |
| Q37249829 | Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome |
| Q42176497 | Sensitive detection of BRAF V600E mutation by Amplification Refractory Mutation System (ARMS)-PCR. |
| Q55313600 | Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy. |
| Q50021960 | Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice |
| Q39041431 | Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line |
| Q94602498 | Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report |
| Q55322225 | Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma. |
| Q42176489 | Suspected anemia caused by maternal anti-Jra antibodies: a case report |
| Q93166064 | TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patients |
| Q92188227 | Targeted therapies for myeloproliferative neoplasms |
| Q129828024 | Targeting TIGIT for cancer immunotherapy: recent advances and future directions |
| Q104133308 | Targeting ferroptosis in breast cancer |
| Q42006192 | The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines |
| Q112611711 | The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma |
| Q64078717 | The association between early neurological deterioration and whole blood purine concentration during acute stroke |
| Q99241129 | The biological function and clinical significance of SF3B1 mutations in cancer |
| Q35983341 | The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer |
| Q42353460 | The drive to generate multiple forms of oncogenic cyclin D1 transcripts in mantle cell lymphoma |
| Q37031281 | The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial |
| Q34256158 | The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes. |
| Q97525711 | The emerging landscape of circular RNAs in immunity: breakthroughs and challenges |
| Q96954205 | The emerging roles of N6-methyladenosine RNA methylation in human cancers |
| Q42560184 | The emerging roles of Notch signaling in leukemia and stem cells |
| Q39045256 | The great masquerader of malignancy: chronic intestinal pseudo-obstruction. |
| Q89821725 | The mir-767-105 cluster: a crucial factor related to the poor prognosis of hepatocellular carcinoma |
| Q59790119 | The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo |
| Q92065233 | The predictive value of tumor mutation burden for immune checkpoint inhibitors therapy in non-small cell lung cancer is affected by patients' age |
| Q37427269 | The progress of targeted therapy in advanced gastric cancer |
| Q34256126 | The resistance mechanisms of proteasome inhibitor bortezomib |
| Q120684896 | The role and metabolic adaptations of neutrophils in premetastatic niches |
| Q114061084 | The role of YAP1 in liver cancer stem cells: proven and potential mechanisms |
| Q99565743 | The role of estrogen receptor beta in breast cancer |
| Q104133744 | The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications |
| Q34285017 | The use of haplotype-specific transcripts improves sample annotation consistency |
| Q64109320 | The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
| Q37658419 | Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. |
| Q33417976 | Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma |
| Q128297339 | Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy |
| Q36671605 | Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma |
| Q95265965 | Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study |
| Q41192352 | Triptolide potentiates lung cancer cells to cisplatin-induced apoptosis by selectively inhibiting the NER activity |
| Q41318642 | Tumor-associated macrophages, potential targets for cancer treatment. |
| Q104470585 | Ultradeep targeted sequencing reveals low allele frequencies of somatic JAK2 and MPL variants in patients with abdominal vein thromboses: results of an ongoing prospective prevalence study in Mecklenburg-West Pomerania |
| Q33893567 | Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy |
| Q38367115 | Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma |
| Q35816851 | Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients |
| Q89821719 | Using toponomics to characterize phenotypic diversity in alveolar macrophages from male mice treated with exogenous SP-A1 |
| Q39194722 | Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response |
| Q34092050 | Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population |
| Q35184951 | Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ |
| Q42918972 | Whole gene expression profile in blood reveals multiple pathways deregulation in R6/2 mouse model |
| Q36639038 | c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia |
| Q55344720 | microRNA based prognostic biomarkers in pancreatic Cancer. |
Search more.